Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice

Erythropoietin (EPO), clinically used as a hematopoietic drug, has received much attention due to its nonhematopoietic effects. EPO reportedly has beneficial effects on obesity and diabetes mellitus. We investigated whether interscapular brown adipose tissue (iBAT: main part of classical BAT) could...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS One
Hlavní autoři: Kodo, Kazuki, Sugimoto, Satoru, Nakajima, Hisakazu, Mori, Jun, Itoh, Ikuyo, Fukuhara, Shota, Shigehara, Keiichi, Nishikawa, Taichiro, Kosaka, Kitaro, Hosoi, Hajime
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5348037/
https://ncbi.nlm.nih.gov/pubmed/28288167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0173661
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky